What to expect when you take Modafinil and Naphazoline hydrochloride?

Do you take Modafinil and Naphazoline hydrochloride? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 20, 2018

4,652 reports have been studied.


Females aged 50 to 59 :

3,232 related reports were analyzed:

Most common symptoms:

Depression
  • 6.37% for females aged 50 (±5) who take Modafinil
Diarrhea
  • 5.57% for females aged 50 (±5) who take Modafinil
Dizziness
  • 6.56% for females aged 50 (±5) who take Modafinil
Fall
  • 8.14% for females aged 50 (±5) who take Modafinil
Fatigue
  • 12.65% for females aged 50 (±5) who take Modafinil
Headache
  • 7.33% for females aged 50 (±5) who take Modafinil
High blood pressure
  • 5.51% for females aged 50 (±5) who take Modafinil
Multiple sclerosis relapse
  • 5.01% for females aged 50 (±5) who take Modafinil
Nausea
  • 10.4% for females aged 50 (±5) who take Modafinil
Pain
  • 6.22% for females aged 50 (±5) who take Modafinil
Stress and anxiety
  • 6.28% for females aged 50 (±5) who take Modafinil
Weakness
  • 7.02% for females aged 50 (±5) who take Modafinil

Most common co-existing conditions:

Depression
  • 11.23% for females aged 50 (±5) who take Modafinil
Multiple sclerosis
  • 40.07% for females aged 50 (±5) who take Modafinil
Pain
  • 7.05% for females aged 50 (±5) who take Modafinil
back to top

Males aged 50 to 59 :

1,420 related reports were analyzed:

Most common symptoms:

Depression
  • 5.14% for males aged 50 (±5) who take Modafinil
Dizziness
  • 6.27% for males aged 50 (±5) who take Modafinil
Fall
  • 6.34% for males aged 50 (±5) who take Modafinil
Fatigue
  • 11.41% for males aged 50 (±5) who take Modafinil
Headache
  • 6.2% for males aged 50 (±5) who take Modafinil
Heart attack
  • 5.07% for males aged 50 (±5) who take Modafinil
High blood pressure
  • 5.0% for males aged 50 (±5) who take Modafinil
Nausea
  • 5.49% for males aged 50 (±5) who take Modafinil
Pain
  • 5.35% for males aged 50 (±5) who take Modafinil
Weakness
  • 5.21% for males aged 50 (±5) who take Modafinil

Most common co-existing conditions:

Depression
  • 11.76% for males aged 50 (±5) who take Modafinil
High blood cholesterol
  • 7.11% for males aged 50 (±5) who take Modafinil
High blood pressure
  • 5.7% for males aged 50 (±5) who take Modafinil
Multiple sclerosis
  • 27.82% for males aged 50 (±5) who take Modafinil
Pain
  • 6.2% for males aged 50 (±5) who take Modafinil
back to top

Do you take Modafinil and Naphazoline hydrochloride:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Modafinil

Modafinil has active ingredients of modafinil. It is often used in narcolepsy. (latest outcomes from Modafinil 8,595 users)

Naphazoline hydrochloride

Naphazoline hydrochloride has active ingredients of naphazoline hydrochloride. (latest outcomes from Naphazoline hydrochloride 28 users)

General study

Related publications that referenced our studies


Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.